Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cerevel Therapeutics Holdings, Inc. - Common Stock
(NQ:
CERE
)
44.96
UNCHANGED
Last Price
Updated: 4:15 PM EDT, Jul 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cerevel Therapeutics Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Why Cerevel Therapeutics Holdings Shares Are Nosediving
November 08, 2022
Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) shares are trading lower by 6.42% to $25.37 during Tuesday's session after the company reported worse-than-expected third-quarter EPS results and filed...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Upgrades
Via
Benzinga
Analyst Ratings for Cerevel Therapeutics Hldg
September 13, 2022
Analysts have provided the following ratings for Cerevel Therapeutics Hldg (NASDAQ:CERE) within the last quarter:
Via
Benzinga
Mizuho Is Bullish On This Schizophrenia-Focused Stock, Read Why
August 23, 2022
Via
Benzinga
Analyst Ratings for Cerevel Therapeutics
August 09, 2022
Cerevel Therapeutics Hldg (NASDAQ:CERE) has observed the following analyst ratings within the last quarter:
Via
Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
October 20, 2022
Cerevel Therapeutics Hldg (NASDAQ:CERE) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
October 20, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022
September 29, 2022
Upgrades
Via
Benzinga
Analyst Ratings for Cerevel Therapeutics Hldg
September 29, 2022
Over the past 3 months, 8 analysts have published their opinion on Cerevel Therapeutics Hldg (NASDAQ:CERE) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022
September 26, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022
September 13, 2022
Upgrades See all analyst ratings upgrades.
Via
Benzinga
Cerevel Therapeutics Shares Are Falling: Here's Why
August 16, 2022
Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) shares are trading lower by 7.1% to $32.00 during Tuesday's trading session. The company on Friday priced its underwritten common stock offering of 7.25...
Via
Benzinga
Bumble, Hanesbrands, Sonos And Some Other Big Losers From Thursday
August 12, 2022
U.S. stocks closed mixed on Thursday following the release of PPI data. Here is the list of some big stocks moving lower in the previous session.
Via
Benzinga
Here's Why Cerevel Therapeutics Stock Is Getting Hammered Today
August 11, 2022
Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) shares are trading lower after the company announced a proposed public offering of $250 million of common stock.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 10, 2022
Via
Benzinga
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
August 12, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results.
Via
Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
August 10, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 09, 2022
Via
Benzinga
GameStop, Signify Health And Some Other Big Gainers From Monday
August 09, 2022
U.S. stocks closed mixed on Monday. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 08, 2022
Via
Benzinga
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
August 09, 2022
Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.
Via
Benzinga
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
August 08, 2022
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6...
Via
Benzinga
iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday
August 08, 2022
U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
Pearson, Nikola And Some Other Big Gainers From Monday
August 02, 2022
U.S. stocks closed slightly lower on Monday, with the Nasdaq Composite dropping around 02%. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday
August 08, 2022
Gainers
Via
Benzinga
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
August 02, 2022
Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday.
Via
Benzinga
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
August 01, 2022
Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022.
Via
Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
August 01, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap: Cerevel Therapeutics Q2 Earnings
August 01, 2022
Cerevel Therapeutics Hldg (NASDAQ:CERE) reported its Q2 earnings results on Monday, August 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For August 1, 2022
August 01, 2022
Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.